Drug intelligence / Profile preview

somatropin depot

Development stage
Discontinued
Lead developer
Genentech
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Subcutaneous
01

Overview

Somatropin depot is a long-acting formulation of recombinant human growth hormone (rhGH), designed for subcutaneous injection once or twice monthly. The product consists of micronized particles of rhGH embedded in biocompatible, biodegradable polylactide-coglycolide (PLG) microspheres. After injection, bioactive rhGH is released from the microspheres by diffusion and polymer degradation. The amino acid sequence is identical to pituitary-derived human growth hormone. Somatropin acts as an agonist at the growth hormone receptor, stimulating tissue growth and metabolism in patients with endogenous growth hormone deficiency or conditions associated with impaired growth[3][4][6]. It was primarily indicated for pediatric patients with inadequate endogenous GH secretion.

Brand names
Nutropin Depot
Other names
somatropin (rDNA origin) for injectable suspensionlong-acting somatropindepot somatropin
02

Targets

GHR (Growth hormone receptor)

Beyond the preview

Go deeper on somatropin depot.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on somatropin depot.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call